Prospective Open-Label Clinical Trial of Trihexyphenidyl in Children With Secondary Dystonia due to Cerebral Palsy

  title={Prospective Open-Label Clinical Trial of Trihexyphenidyl in Children With Secondary Dystonia due to Cerebral Palsy},
  author={Terence D. Sanger and Amy J. Bastian and Janice E. Brunstrom and Diane L. Damiano and Mauricio R Delgado and Leon Dure and Deborah J. Gaebler-Spira and Alexander Hoon and Jonathan W. Mink and Sara Sherman-Levine and Leah J. Welty},
  journal={Journal of Child Neurology},
  pages={530 - 537}
Although trihexyphenidyl is used clinically to treat both primary and secondary dystonia in children, limited evidence exists to support its effectiveness, particularly in dystonia secondary to disorders such as cerebral palsy. A prospective, open-label, multicenter pilot trial of high-dose trihexyphenidyl was conducted in 23 children aged 4 to 15 years with cerebral palsy judged to have secondary dystonia impairing function in the dominant upper extremity. All children were given… 

Figures and Tables from this paper

Response to Correspondence on “Prospective Open-Label Clinical Trial of Trihexyphenidyl in Children With Secondary Dystonia due to Cerebral Palsy”
Trihexyphenidyl may be a safe and effective for treatment for arm dystonia in some children with cerebral palsy if given sufficient time to respond to the medication, according to post hoc analyses based on the type of movement disorder.
Pilot Study on Trihexyphenidyl in the Treatment of Dystonia in Children With Cerebral Palsy
There were no significant treatment effects as measured by change in outcome scores, and there were significant order effects for both the Goal Attainment Scale and performance aspect of the Canadian Occupational Performance Measure.
Trihexyphenidyl Improves Motor Function in Children with Dystonic Cerebral Palsy: A Retrospective Analysis
  • H. Ben-Pazi
  • Medicine, Psychology
    Journal of child neurology
  • 2011
In summary, trihexyphenidyl is effective particularly in absence of spasticity and in children with higher cognitive abilities.
Trihexyphenidyl for dystonia in cerebral palsy.
The effects of trihexyphenidyl in people with dystonic cerebral palsy, according to the World Health Organization's (WHO) International Classification of Functioning, Disability and Health (ICF) domains of impairment, activity and participation, are assessed.
Intrathecal baclofen treatment in dystonic cerebral palsy: a randomized clinical trial: the IDYS trial
The primary aim of this study is to provide level one clinical evidence for the effects of intrathecal baclofen treatment on the level of activities and participation in dystonic cerebral palsy patients, and to identify clinical characteristics that will predict a beneficial effect of intrathletic bacl ofen in an individual patient.
Upper Limbs Function After Intrathecal Baclofen Therapy in Children With Secondary Dystonia
In patients with secondary dystonia treated with ITB, functional improvement of the upper limbs was observed in addition to dySTONia reduction, and a statistically significant improvement in both scales was found.
Responsiveness of the MD-childhood rating scale in dyskinetic cerebral palsy patients undergoing anticholinergic treatment.
  • R. Battini, M. Casarano, G. Cioni
  • Medicine, Psychology
    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
  • 2014
Effects of intrathecal baclofen on daily care in children with secondary generalized dystonia: a pilot study.
Treatment of Generalized Dystonia
DBS can restore normal or near-normal functioning and avoid the physical and emotional costs of an extended period of decreased physical and social functioning and should be considered as a treatment option for any patient with severe, medically refractory dystonia.


Age-dependent effects of trihexyphenidyl in extrapyramidal cerebral palsy.
Treatment of movement disorders with trihexyphenidyl
Three groups of movement disorders demonstrated a significant response to trihexyphenidyl: dystonia 37%; tonic torticollis demonstrated a significantly better response than the clonic variant, and rhythmic‐oscillatory movements of brainstem–cerebellar origin 90%; and cerebellar tremor 75%.
The treatment of severe dystonia in children and adults.
It is concluded that high dose benzhexol is the present first treatment of choice for children with severe dystonia, and is worth a try in adults but with less expectation of success.
Torsion dystonia
High-dosage trihexyphenidyl therapy is effective in the management of torsion dystonia and the 30-mg dose used was generally well tolerated.
High dosage anticholinergic therapy in dystonia
  • S. Fahn
  • Medicine, Psychology
  • 1983
Twenty-three children and 52 adults with torsion dystonia of various etiologies and distribution patterns of the involuntary movements were treated in an open-label study with anticholinergic medication, and significant benefit occurred in 61% of children and in 38% of adults.
Oral Pharmacotherapy for the Movement Disorders of Cerebral Palsy
This review attempts to summarize empiric drug use and recommendations for therapy, drug studies in extrapyramidal cerebral palsy, and prospects for new drugs or models for the problem.
Classification and definition of disorders causing hypertonia in childhood.
The purpose of the workshop and this article are to define the terms "spasticity," "dystonia," and "rigidity" as they are used to describe clinical features of hypertonia in children to allow differentiation of clinical features even when more than 1 is present simultaneously.
Efficacy of pharmacological treatment of dystonia: evidence‐based review including meta‐analysis of the effect of botulinum toxin and other cure options
A literature review based on MEDLINE and the Cochrane Library and manual search of the most important journals was performed to identify the relevant publications issued between 1973 and 2003 concluded that botulinum toxin has obvious benefit and trihexyphenidyl in high dosages is effective for the treatment of segmental and generalized dystonia in young patients.
Delayed-onset progressive movement disorders after static brain lesions
Brain injury at a young age is associated with a longer latency to onset of subsequent movement disorder, a greater tendency to development of generalized dystonia, and a greater probability of altered handedness.
Reliability of the Melbourne assessment of unilateral upper limb function.
Findings indicate that the Melbourne Assessment of Unilateral Upper Limb Function is a reliable tool for measuring the quality of unilateral upper-limb movement in children with CP.